WPRIM Management System> DCMS> Journal of China Pharmaceutical University> 2019> 50> 1

Volume: 50 Issue: 1

1. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway Page:1—10
2. Strategies of nano drug delivery system applied in anti-angiogenic therapy Page:11—18
3. Chemistry of steroidal saponins as natural resource compounds Page:19—32
4. Progress in the analysis of adulterated additives in traditional Chinese medicines and health care products Page:33—40
5. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity Page:41—45
6. Isolation and identification of antitumor constituents from Trichosanthes tricuspidata Page:46—52
7. Preparation and in vitro evaluation of pregabalin controlled porosity osmotic pump tablets Page:53—58
8. Analysis of the differential compounds in Astragalus membranaceus from different geographical origins by UFLC-IT-TOF/MS Page:59—65
9. Analysis of transcriptome sequencing and related genes of flavonoid biosynthesis from Anoectochilus roxburghii Page:66—74
10. Pharmacokinetics and absolute bioavailability of isoschaftoside in rat by LC-MS/MS Page:75—80
11. Comparative investigation of in vitro antitumor activity of Ganoderma lucidum spore oil Page:81—86
12. Antipyretic effect of Isodon eriocalyx extracts on yeast-induced fever in rats Page:87—92
13. Expression, purification and NETs degradation activity of human DNase I Page:93—99
14. Research progress of carbon nanomaterials in cancer drug delivery Page:100—106
15. Role of non-coding RNA in pulmonary arterial hypertension Page:107—112
16. Major routes for orphan drugs to be incorporated into the reimbursement system of UK and the enlightenment to China Page:113—119
17. Research on exporting competitiveness of pharmaceuticals in China Page:120—126

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.